{"product_id":"cjc-1295-no-dac-ipamorelin-blend","title":"CJC 1295 No Dac + Ipamorelin Blend","description":"\u003ch2\u003e\n  \u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-blend\"\u003e\n    Prime Peptide's CJC-1295 No DAC + Ipamorelin research blend\n  \u003c\/a\u003e\n\u003c\/h2\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC + Ipamorelin is a dual-peptide laboratory research blend designed for controlled studies involving growth hormone signalling, receptor activity and peptide interaction pathways. By combining two widely studied compounds in a single research material, this blend allows researchers to explore their complementary mechanisms within one consistent preparation.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC, also known as Modified GRF 1-29, is a short-acting growth hormone-releasing hormone analogue. Ipamorelin is a selective growth hormone secretagogue commonly studied for its interaction with the ghrelin receptor. Together, these peptides are frequently investigated in laboratory models examining pulsatile growth hormone release, receptor selectivity and coordinated peptide signalling.\n\u003c\/p\u003e\n\n\u003ch2\u003eWhat is CJC-1295 No DAC + Ipamorelin?\u003c\/h2\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC and Ipamorelin act through different but related signalling pathways. CJC-1295 No DAC is studied for its interaction with growth hormone-releasing hormone receptors, while Ipamorelin is researched for its activity at growth hormone secretagogue receptors.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Because the two compounds operate through distinct receptor systems, the combination is commonly used in research focused on synergistic peptide activity, endocrine signalling patterns and coordinated growth hormone pathway stimulation.\n\u003c\/p\u003e\n\n\u003ch2\u003eAbout CJC-1295 No DAC\u003c\/h2\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC is the short-acting form of Modified GRF 1-29. Unlike DAC-modified versions, it does not contain the Drug Affinity Complex component that extends circulation time. This makes CJC-1295 No DAC particularly relevant for research examining shorter-duration signalling and naturally patterned peptide activity.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Laboratory investigations involving CJC-1295 No DAC often focus on growth hormone-releasing hormone receptor activation, pituitary signalling and time-dependent hormone release models.\n\u003c\/p\u003e\n\n\u003ch2\u003eAbout Ipamorelin\u003c\/h2\u003e\n\n\u003cp\u003e\n  Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. It is primarily studied for its interaction with the ghrelin receptor, also known as the growth hormone secretagogue receptor.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Researchers frequently evaluate Ipamorelin because of its receptor selectivity and its role in laboratory models involving peptide-induced growth hormone signalling. Its selective profile makes it useful in comparative studies involving other growth hormone secretagogues.\n\u003c\/p\u003e\n\n\u003ch2\u003eWhy researchers study the blend\u003c\/h2\u003e\n\n\u003cp\u003e\n  The CJC-1295 No DAC + Ipamorelin blend is commonly selected for research where two complementary peptide pathways need to be evaluated together. Combining a growth hormone-releasing hormone analogue with a growth hormone secretagogue allows researchers to investigate how separate receptor systems may interact within the same experimental model.\n\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDual-pathway research:\u003c\/strong\u003e Supports investigation of both GHRH receptor and ghrelin receptor signalling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSynergistic models:\u003c\/strong\u003e Useful for studies examining coordinated peptide activity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eShort-acting research profile:\u003c\/strong\u003e CJC-1295 No DAC is suitable for studies focused on pulsatile or time-dependent signalling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSelective receptor activity:\u003c\/strong\u003e Ipamorelin is frequently researched for its relatively selective secretagogue profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsistent blend format:\u003c\/strong\u003e Both peptides are supplied together for convenient laboratory preparation and comparison.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch applications\u003c\/h2\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC + Ipamorelin may be used in controlled laboratory research involving:\n\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003egrowth hormone signalling pathways\u003c\/li\u003e\n  \u003cli\u003egrowth hormone-releasing hormone receptor activity\u003c\/li\u003e\n  \u003cli\u003eghrelin receptor interaction\u003c\/li\u003e\n  \u003cli\u003epulsatile endocrine signalling models\u003c\/li\u003e\n  \u003cli\u003epeptide synergy and receptor cross-talk\u003c\/li\u003e\n  \u003cli\u003ecellular signalling associated with growth hormone pathways\u003c\/li\u003e\n  \u003cli\u003ecomparative analysis of peptide secretagogues\u003c\/li\u003e\n  \u003cli\u003etime-dependent peptide response studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eProduct information\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProduct:\u003c\/strong\u003e CJC-1295 No DAC + Ipamorelin Blend\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCompound type:\u003c\/strong\u003e Dual-peptide research material\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePresentation:\u003c\/strong\u003e Sealed laboratory vial\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResearch category:\u003c\/strong\u003e GHRH analogue and growth hormone secretagogue blend\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIntended use:\u003c\/strong\u003e Laboratory and analytical research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality and consistency\u003c\/h2\u003e\n\n\u003cp\u003e\n  Prime Peptide supplies CJC-1295 No DAC + Ipamorelin as a premium laboratory research blend prepared with attention to purity, consistency and handling quality. A reliable blend format helps researchers reduce variation between individual preparations and maintain greater consistency across repeated experiments.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Each vial is intended to support controlled research environments where accurate identification, reliable presentation and consistent material quality are important.\n\u003c\/p\u003e\n\n\u003ch2\u003eStorage and handling\u003c\/h2\u003e\n\n\u003cp\u003e\n  Store the unopened lyophilised vial in a cool, dry environment away from direct sunlight, heat and moisture. For longer-term laboratory storage, refrigeration may be preferred depending on the research protocol and available stability documentation.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Once prepared for laboratory use, the material should be handled using appropriate sterile research procedures. Avoid repeated temperature fluctuations and unnecessary exposure to light.\n\u003c\/p\u003e\n\n\u003ch2\u003eOrdering CJC-1295 No DAC + Ipamorelin in India\u003c\/h2\u003e\n\n\u003cp\u003e\n  Prime Peptide provides CJC-1295 No DAC + Ipamorelin research material for laboratories, institutions and qualified researchers across India. Orders are securely packed to help protect vial integrity during transit.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  Before placing an order, researchers should confirm the required blend strength, laboratory protocol and storage conditions. Product availability and specifications may vary, so the selected vial details should be reviewed carefully before checkout.\n\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eWhat is the difference between CJC-1295 No DAC and CJC-1295 with DAC?\u003c\/h3\u003e\n\n\u003cp\u003e\n  CJC-1295 No DAC is a shorter-acting GHRH analogue commonly associated with pulsatile research models. CJC-1295 with DAC contains a modification designed to extend its duration of activity.\n\u003c\/p\u003e\n\n\u003ch3\u003eWhy are CJC-1295 No DAC and Ipamorelin combined?\u003c\/h3\u003e\n\n\u003cp\u003e\n  The blend combines two peptides that act through different receptor pathways. CJC-1295 No DAC is studied for GHRH receptor activity, while Ipamorelin is studied for growth hormone secretagogue receptor activity. Researchers may use the combination to examine coordinated or complementary signalling.\n\u003c\/p\u003e\n\n\u003ch3\u003eIs the product supplied as a lyophilised powder?\u003c\/h3\u003e\n\n\u003cp\u003e\n  Yes. The blend is generally supplied in lyophilised form to support stability during storage and transport.\n\u003c\/p\u003e\n\n\u003ch3\u003eIs CJC-1295 No DAC + Ipamorelin intended for laboratory research?\u003c\/h3\u003e\n\n\u003cp\u003e\n  Yes. This material is supplied exclusively for controlled laboratory, analytical and scientific research.\n\u003c\/p\u003e\n\n\u003ch3\u003eDoes the blend contain CJC-1295 with DAC?\u003c\/h3\u003e\n\n\u003cp\u003e\n  No. This blend contains CJC-1295 No DAC, also known as Modified GRF 1-29, together with Ipamorelin.\n\u003c\/p\u003e\n\n\u003ch2\u003eResearch use disclaimer\u003c\/h2\u003e\n\n\u003cp\u003e\n  This material is not a medicine, supplement, cosmetic or food product and is intended exclusively for laboratory research. It is not intended for human or veterinary administration, diagnosis or treatment.\n\u003c\/p\u003e\n","brand":"Prime Peptide","offers":[{"title":"10 MG","offer_id":58262431105327,"sku":null,"price":4199.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0986\/4331\/2943\/files\/ipamorelin_10mg.png?v=1785318605","url":"https:\/\/primepeptide.in\/products\/cjc-1295-no-dac-ipamorelin-blend","provider":"Prime Peptide","version":"1.0","type":"link"}